Related references
Note: Only part of the references are listed.Development of a new model of reconstituted mouse epidermis and characterization of its response to proinflammatory cytokines
Mathilde Pohin et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2018)
Increased epidermal thickness and abnormal epidermal differentiation in keloid scars
G. C. Limandjaja et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Oncostatin M overexpression induces skin inflammation but is not required in the mouse model of imiquimod-induced psoriasis-like inflammation
Mathilde Pohin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Oncostatin M overexpression induces matrix deposition, STAT3 activation, and SMAD1 Dysregulation in lungs of fibrosis-resistant BALB/c mice
Steven Wong et al.
LABORATORY INVESTIGATION (2014)
Comparative proteomic analysis of extracellular matrix proteins secreted by hypertrophic scar with normal skin fibroblasts
Li Ma et al.
BURNS & TRAUMA (2014)
Involvement of IL-1 and Oncostatin M in Acanthosis Associated With Hypertensive Leg Ulcer
Jean-Philippe Giot et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Increased KGF Expression Promotes Fibroblast Activation in a Double Paracrine Manner Resulting in Cutaneous Fibrosis
Johanna Canady et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Oncostatin M inhibits TGF-β1-induced CTGF expression via STAT3 in human proximal tubular cells
Rita Sarkoezi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Oncostatin M decreases interleukin-1 ß secretion by human synovial fibroblasts and attenuates an acute inflammatory reaction in vivo
Aline Dumas et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
A Mouse Model of Airway Disease: Oncostatin M-Induced Pulmonary Eosinophilia, Goblet Cell Hyperplasia, and Airway Hyperresponsiveness Are STAT6 Dependent, and Interstitial Pulmonary Fibrosis Is STAT6 Independent
Dominik K. Fritz et al.
JOURNAL OF IMMUNOLOGY (2011)
Oncostatin M is a novel inhibitor of TGF-β1-induced matricellular protein expression
Rita Sarkoezi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Comparative proteomic analysis between normal skin and keloid scar
C. T. Ong et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1α, and TNF-α Recapitulates Some Features of Psoriasis
Karline Guilloteau et al.
JOURNAL OF IMMUNOLOGY (2010)
Early Differential Expression of Oncostatin M in Obstructive Nephropathy
Wafa M. Elbjeirami et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Molecular dissection of abnormal wound healing processes resulting in keloid disease
Barbara Shih et al.
WOUND REPAIR AND REGENERATION (2010)
Hypertrophic Scars and Keloids-A Review of Their Pathophysiology, Risk Factors, and Therapeutic Management
Dolores Wolfram et al.
DERMATOLOGIC SURGERY (2009)
Keloids: Current concepts of pathogenesis (Review)
Gregor M. Bran et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2009)
Tumor-Like Stem Cells Derived from Human Keloid Are Governed by the Inflammatory Niche Driven by IL-17/IL-6 Axis
Qunzhou Zhang et al.
PLOS ONE (2009)
Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis
Pauline D. H. M. Verhaegen et al.
WOUND REPAIR AND REGENERATION (2009)
Mechanisms of Oncostatin M-Induced Pulmonary Inflammation and Fibrosis
Afsaneh Mozaffarian et al.
JOURNAL OF IMMUNOLOGY (2008)
Current progress in keloid research and treatment
Paris D. Butler et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation
Katia Boniface et al.
JOURNAL OF IMMUNOLOGY (2007)
Prostaglandin E2 inhibition of keloid fibroblast migration, contraction, and transforming growth factor (TGF)-beta 1-induced collagen synthesis
Vlad C. Sandulache et al.
WOUND REPAIR AND REGENERATION (2007)
Functional implications of the IL-6 signaling pathway in keloid pathogenesis
Mohammad Ghazizadeh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management
Alison E. Slemp et al.
CURRENT OPINION IN PEDIATRICS (2006)
Keloid-derived fibroblasts have a diminished capacity to produce prostaglandin E2
FL Yeh et al.
BURNS (2006)
Oncostatin M expression is functionally connected to neutrophils in the early inflammatory phase of skin repair:: Implications for normal and diabetes-impaired wounds
Itamar Goren et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Inflammatory cells during wound, repair: the good, the bad and the ugly
P Martin et al.
TRENDS IN CELL BIOLOGY (2005)
Keloid or hypertrophic scar - The controversy: Review of the literature
BS Atiyeh et al.
ANNALS OF PLASTIC SURGERY (2005)
Inflammation in surgical wound healing: Friend or foe?
AM Szpaderska et al.
SURGERY (2005)
Epidermis promotes dermal fibrosis:: role in the pathogenesis of hypertrophic scars
J Bellemare et al.
JOURNAL OF PATHOLOGY (2005)
IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes
K Boniface et al.
JOURNAL OF IMMUNOLOGY (2005)
Expression of p53 family in scars
A Tanaka et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2004)
Hypertrophic scar formation is associated with an increased number of epidermal Langerhans cells
FB Niessen et al.
JOURNAL OF PATHOLOGY (2004)
Histopathological differential diagnosis of keloid and hypertrophic scar
JYY Lee et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2004)
Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts: An important role in the pathogenesis of keloid
E Funayama et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis
JJ Kaden et al.
ATHEROSCLEROSIS (2003)
Analysis of differentially expressed genes in keloids and normal skin with cDNA microarray
W Chen et al.
JOURNAL OF SURGICAL RESEARCH (2003)
Oncostatin M stimulates proliferation, induces collagen production and inhibits apoptosis of human lung fibroblasts
AK Scaffidi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Fibroblasts cocultured with keloid keratinocytes: normal fibroblasts secrete collagen in a keloidlike manner
IJ Lim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Differential expression of transforming growth factor-β receptors I and II and activation of Smad 3 in keloid fibroblasts
GS Chin et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2001)
Keloids and hypertrophic soars of Caucasians show distinctive morphologic and immunophenotypic profiles
M Santucci et al.
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2001)
Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro
IJ Lim et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2001)
Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway
H Ihn et al.
JOURNAL OF IMMUNOLOGY (2000)
Oncostatin M: a cytokine upregulated in human cirrhosis, increases collagen production by human hepatic stellate cells
MT Levy et al.
JOURNAL OF HEPATOLOGY (2000)
Share Paper
